CHEBI:145330 - 1-hydroxymidazolam

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name 1-hydroxymidazolam
ChEBI ID CHEBI:145330
Definition An imidazobenzodiazepine that is midazolam in which one of the hydrogens of the methyl group is substituted by a hydroxy group. It is the major metabolite of the anesthetic, midazolam.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C18H13ClFN3O
Net Charge 0
Average Mass 341.770
Monoisotopic Mass 341.07312
InChI InChI=1S/C18H13ClFN3O/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)22-9-12-8-21-17(10-24)23(12)16/h1-8,24H,9-10H2
InChIKey QHSMEGADRFZVNE-UHFFFAOYSA-N
SMILES C1(=NCC=2N(C=3C1=CC(=CC3)Cl)C(=NC2)CO)C=4C=CC=CC4F
Metabolite of Species Details
Homo sapiens (NCBI:txid9606) Found in blood plasma (BTO_0000131). See: PubMed
Homo sapiens (NCBI:txid9606) Found in blood serum (BTO:0000133). See: PubMed
Homo sapiens (NCBI:txid9606) Found in urine (BTO:0001419). See: PubMed
Roles Classification
Biological Role(s): drug metabolite

human blood serum metabolite
Any metabolite (endogenous or exogenous) found in human blood serum samples.
human urinary metabolite
Any metabolite (endogenous or exogenous) found in human urine samples.
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via benzodiazepine )
Application(s): GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via benzodiazepine )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing 1-hydroxymidazolam (CHEBI:145330) has functional parent midazolam (CHEBI:6931)
1-hydroxymidazolam (CHEBI:145330) has role drug metabolite (CHEBI:49103)
1-hydroxymidazolam (CHEBI:145330) has role human blood serum metabolite (CHEBI:85234)
1-hydroxymidazolam (CHEBI:145330) has role human urinary metabolite (CHEBI:84087)
1-hydroxymidazolam (CHEBI:145330) is a aromatic primary alcohol (CHEBI:33857)
1-hydroxymidazolam (CHEBI:145330) is a imidazobenzodiazepine (CHEBI:142118)
1-hydroxymidazolam (CHEBI:145330) is a monofluorobenzenes (CHEBI:83575)
1-hydroxymidazolam (CHEBI:145330) is a organochlorine compound (CHEBI:36683)
Incoming 1-hydroxymidazolam β-D-glucuronide (CHEBI:145334) has functional parent 1-hydroxymidazolam (CHEBI:145330)
IUPAC Name
[8-chloro-6-(2-fluorophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepin-1-yl]methanol
Synonyms Sources
1'-hydroxymidazolam ChEBI
1-hydroxymethylmidazolam ChemIDplus
1-OH-MDZ ChemIDplus
8-chloro-6-(2-fluorophenyl)-1-hydroxymethyl-4H-imidazo[1,5-a][1,4]benzodiazepine ChEBI
8-chloro-6-(2-fluorophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-1-methanol ChEBI
α-hydroxymidazolam ChemIDplus
Ro 21-6347 ChEBI
Manual Xref Database
HMDB0061089 HMDB
View more database links
Registry Number Type Source
59468-90-5 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
15914101 PubMed citation Europe PMC
17452028 PubMed citation Europe PMC
20850770 PubMed citation Europe PMC
21204116 PubMed citation Europe PMC
21531182 PubMed citation Europe PMC
21993197 PubMed citation Europe PMC
23674377 PubMed citation Europe PMC
28615640 PubMed citation Europe PMC
28978489 PubMed citation Europe PMC
31469454 PubMed citation Europe PMC
6691561 PubMed citation Europe PMC
7199324 PubMed citation Europe PMC
7603229 PubMed citation Europe PMC
8924728 PubMed citation Europe PMC
9187388 PubMed citation Europe PMC
9725490 PubMed citation Europe PMC
Last Modified
11 November 2019